[NOT AVAILABLE ON DEMAND] Short Talk: Knockout of NKG2A by CRISPR in Human NK Cells Enhance their Cytotoxic Activity Against Solid Tumors

Date

March 9, 2021

Speaker

Delphine Guipouy, PhD

CHU Sainte Justine Research Center

Tracks

Therapeutics I: Ex Vivo Editing

Related Products

Thumbnail for T-Cell Gene Editing for Cancer Immunotherapy

T-Cell Gene Editing for Cancer Immunotherapy

Thumbnail for An Adenine Base Editing Strategy for the Treatment of Sickle Cell Disease by Elimination of the Pathogenic Globin Protein

An Adenine Base Editing Strategy for the Treatment of Sickle Cell Disease by Elimination of the Pathogenic Globin Protein

Thumbnail for Genome Editing of Blood Cells to Cure Disease

Genome Editing of Blood Cells to Cure Disease

Thumbnail for Short Talk: Expanding the Scope of Marker-Free Selection for CRISPR-Driven Genome Editing in Human Cells

Short Talk: Expanding the Scope of Marker-Free Selection for CRISPR-Driven Genome Editing in Human Cells

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.